Millennium Management
CAPR icon

Millennium Management’s Capricor Therapeutics CAPR Stock Holding History

Millennium Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8M Sell
356,354
-325,990
-48% -$8.69M ﹤0.01% 2096
2025
Q4 		$19.7M Buy
682,344
+479,885
+237% +$6.27M 0.01% 1594
2025
Q3 		$1.46M Buy
202,459
+28,611
+16% +$211K ﹤0.01% 4328
2025
Q2 		$1.73M Sell
173,848
-48,222
-22% -$509K ﹤0.01% 4009
2025
Q1 		$2.11M Buy
222,070
+106,428
+92% +$1.48M ﹤0.01% 3726
2024
Q4 		$1.6M Buy
115,642
+20,885
+22% +$366K ﹤0.01% 3815
2024
Q3 		$1.44M Sell
94,757
-384,753
-80% -$1.9M ﹤0.01% 3985
2024
Q2 		$2.29M Buy
479,510
+186,469
+64% +$1.04M ﹤0.01% 3428
2024
Q1 		$1.99M Buy
293,041
+272,003
+1,293% +$1.32M ﹤0.01% 3744
2023
Q4 		$103K Sell
21,038
-23,750
-53% -$77.3K ﹤0.01% 5342
2023
Q3 		$153K Buy
+44,788
New +$252K ﹤0.01% 5217
2023
Q1 		– Sell
-52,728
Closed -$204K – 6401
2022
Q4 		$204K Buy
52,728
+25,440
+93% +$121K ﹤0.01% 5324
2022
Q3 		$164K Buy
+27,288
New +$140K ﹤0.01% 5761
2021
Q3 		– Sell
-13,544
Closed -$69K – 6805
2021
Q2 		$69K Sell
13,544
-8,846
-40% -$37.5K ﹤0.01% 6323
2021
Q1 		$105K Sell
22,390
-26,967
-55% -$155K ﹤0.01% 5680
2020
Q4 		$169K Buy
+49,357
New +$214K ﹤0.01% 4904
2016
Q3 		– Sell
-1,857
Closed -$73K – 3280
2016
Q2 		$73K Hold
1,857
– – ﹤0.01% 3052
2016
Q1 		$47K Hold
1,857
– – ﹤0.01% 3154
2015
Q4 		$57K Hold
1,857
– – ﹤0.01% 3300
2015
Q3 		$75K Hold
1,857
– – ﹤0.01% 3306
2015
Q2 		$94K Hold
1,857
– – ﹤0.01% 3177
2015
Q1 		$160K Buy
+1,857
New +$160K ﹤0.01% 3339

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management's CAPR Position: Q1 2026 in Review

Millennium Management reduced its Capricor Therapeutics (CAPR) stake by 48% in Q1 2026, selling an estimated $8.69M and leaving 356,354 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Millennium Management first reported a position in CAPR in Q1 2015 and has held it in 22 quarters since. The position peaked at $19.7M in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Millennium Management held 356,354 shares of Capricor Therapeutics worth $10.8M as of Q1 2026.
  • Millennium Management sold 325,990 Capricor Therapeutics shares in Q1 2026, an estimated $8.69M.
  • Capricor Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2096 holding.
  • Millennium Management first reported a position in Capricor Therapeutics in Q1 2015 and has held it in 22 quarters since.
  • Millennium Management's Capricor Therapeutics position peaked at $19.7M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.